header-logo header-logo

31 March 2017 / David Locke
Issue: 7740 / Categories: Features
printer mail-detail

The final chance

nlj_7740_locke

The law should not underestimate the desire of terminally ill patients to make a final & important contribution to medical advancement, says David Locke​

  • Why should a properly informed patient not be able to exercise their autonomy to elect for novel medical treatment

There are clearly many occasions when being first is an advantage, but just occasionally it is rather less obviously a benefit. One cannot, for example, easily conceive of how it might feel to be the first person put under anaesthetic to undergo a new experimental surgical procedure. It must be times like that when the benefits of evidence based medicine come into a very stark and individual perspective. After all, isn’t that what evidence-based medicine is when reduced to the personal level: the idea that enough people have already had it done to them so that you can be reasonably sure what the outcome is likely to be for you ?

Nonetheless, someone always has to be first and for every patient who undergoes a new treatment there must be a medical professional who is prepared to put their reputation and

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Jurit LLP—Caroline Williams

Jurit LLP—Caroline Williams

Private wealth and tax team welcomes cross-border specialist as consultant

Freeths—Michelle Kirkland Elias

Freeths—Michelle Kirkland Elias

International hospitality and leisure specialist joins corporate team as partner

Flint Bishop—Deborah Niven

Flint Bishop—Deborah Niven

Firm appoints head of intellectual property to drive northern growth

NEWS
Talk of a reserved ‘Welsh seat’ on the Supreme Court is misplaced. In NLJ this week, Professor Graham Zellick KC explains that the Constitutional Reform Act treats ‘England and Wales’ as one jurisdiction, with no statutory Welsh slot
The government’s plan to curb jury trials has sparked ‘jury furore’. Writing in NLJ this week, David Locke, partner at Hill Dickinson, says the rationale is ‘grossly inadequate’
A year after the $1.5bn Bybit heist, crypto fraud is booming—but so is recovery. Writing in NLJ this week, Neil Holloway, founder and CEO of M2 Recovery, warns that scams hit at least $14bn in 2025, fuelled by ‘pig butchering’ cons and AI deepfakes
After Woodcock confirmed no general duty to warn, debate turns to the criminal law. Writing in NLJ this week, Charles Davey of The Barrister Group urges revival of misprision or a modern equivalent
Family courts are tightening control of expert evidence. Writing in NLJ this week, Dr Chris Pamplin says there is ‘no automatic right’ to call experts; attendance must be ‘necessary in the interests of justice’ under FPR Pt 25
back-to-top-scroll